Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7014
Rank
HK$4.06 B
Marketcap
HK$203.05
Share price
-2.60%
Change (1 day)
-21.63%
Change (1 year)

Financial Statements

Thumbnail Avalon Pharma (Middle East Pharmaceutical) Financial Statement 2023

Financial Statement 2023

Language: English

View Financial Statement